Merck Seeks U.S. Emergency Approval For Antiviral Covid Pill

A late-stage trial showed the pill, which Merck is developing with Miami-based Ridgeback Therapeutics, halves the chances of hospitalization or death in recently diagnosed patients at risk of severe illness.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive